Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Methyltransferase Recruitment and DNA Hypermethylation of Target Promoters by an Oncogenic Transcription Factor
Luciano Di Croce,1*Veronica A. Raker,1Massimo Corsaro,1Francesco Fazi,2Mirco Fanelli,15Mario Faretta,1Francois Fuks,4Francesco Lo Coco,3Tony Kouzarides,4Clara Nervi,2Saverio Minucci,1Pier Giuseppe Pelicci16*
DNA methylation of tumor suppressor genes is a frequent
mechanism of transcriptional silencing in cancer. The molecular
mechanismsunderlying the specificity of methylation are unknown. We
reporthere that the leukemia-promoting PML-RAR fusion protein inducesgene hypermethylation and silencing by recruiting DNA
methyltransferasesto target promoters and that hypermethylation
contributes to itsleukemogenic potential. Retinoic acid treatment
induces promoterdemethylation, gene reexpression, and reversion of the
transformedphenotype. These results establish a mechanistic link
betweengenetic and epigenetic changes during transformation and
suggestthat hypermethylation contributes to the early steps of
carcinogenesis.
1 Department of Experimental Oncology, European
Institute of Oncology, Milan, Italy.
2 Department of
Histology and Medical Embryology,
3 Department of
Cellular Biotechnology and Hematology, University of Rome, "La
Sapienza," Rome, Italy.
4 Wellcome/CRC Institute
and Department of Pathology, Cambridge University, Cambridge, UK.
5 Department of Morphological Science, University of
Camerino, Italy.
6 Italian Foundation for Cancer
Research (FIRC) Institute for Molecular Oncology, Milan, Italy.
*
To whom correspondence should be addressed. E-mail:
ldicroce{at}lar.ieo.it (L.D.C.); pgpelicci{at}ieo.it (P.G.P.)
The editors suggest the following Related Resources on Science sites:
Targeting PML-RAR{alpha} and Oncogenic Signaling Pathways by Chinese Herbal Mixture Tien-Hsien Liquid in Acute Promyelocytic Leukemia NB4 Cells.
C.-J. Yao, C.-M. Yang, S.-E. Chuang, J.-L. Yan, C.-Y. Liu, S.-W. Chen, K.-H. Yan, T.-Y. Lai, and G.-M. Lai (2009)
Evid. Based Complement. Altern. Med.
|Abstract »|Full Text »|PDF »
Valproic Acid at Therapeutic Plasma Levels May Increase 5-Azacytidine Efficacy in Higher Risk Myelodysplastic Syndromes.
M. T. Voso, V. Santini, C. Finelli, P. Musto, E. Pogliani, E. Angelucci, G. Fioritoni, G. Alimena, L. Maurillo, A. Cortelezzi, et al. (2009)
Clin. Cancer Res.
15, 5002-5007
|Abstract »|Full Text »|PDF »
A Label-free Quantitative Proteomics Strategy to Identify E3 Ubiquitin Ligase Substrates Targeted to Proteasome Degradation.
C. F. Burande, M. L. Heuze, I. Lamsoul, B. Monsarrat, S. Uttenweiler-Joseph, and P. G. Lutz (2009)
Mol. Cell. Proteomics
8, 1719-1727
|Abstract »|Full Text »|PDF »
Cancer DNA Methylation: Molecular Mechanisms and Clinical Implications.
M. T. McCabe, J. C. Brandes, and P. M. Vertino (2009)
Clin. Cancer Res.
15, 3927-3937
|Abstract »|Full Text »|PDF »
The PRC1 Polycomb group complex interacts with PLZF/RARA to mediate leukemic transformation.
H. Boukarabila, A. J. Saurin, E. Batsche, N. Mossadegh, M. van Lohuizen, A. P. Otte, J. Pradel, C. Muchardt, M. Sieweke, and E. Duprez (2009)
Genes & Dev.
23, 1195-1206
|Abstract »|Full Text »|PDF »
Differentiation therapy of leukemia: 3 decades of development.
SALL3 Interacts with DNMT3A and Shows the Ability To Inhibit CpG Island Methylation in Hepatocellular Carcinoma.
Y. Shikauchi, A. Saiura, T. Kubo, Y. Niwa, J. Yamamoto, Y. Murase, and H. Yoshikawa (2009)
Mol. Cell. Biol.
29, 1944-1958
|Abstract »|Full Text »|PDF »
Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells.
P.-O. Esteve, H. G. Chin, J. Benner, G. R. Feehery, M. Samaranayake, G. A. Horwitz, S. E. Jacobsen, and S. Pradhan (2009)
PNAS
106, 5076-5081
|Abstract »|Full Text »|PDF »
Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid features.
M. E. Figueroa, B. J. Wouters, L. Skrabanek, J. Glass, Y. Li, C. A. J. Erpelinck-Verschueren, A. W. Langerak, B. Lowenberg, M. Fazzari, J. M. Greally, et al. (2009)
Blood
113, 2795-2804
|Abstract »|Full Text »|PDF »
A Multifactorial Signature of DNA Sequence and Polycomb Binding Predicts Aberrant CpG Island Methylation.
MBD3, a Component of the NuRD Complex, Facilitates Chromatin Alteration and Deposition of Epigenetic Marks.
L. Morey, C. Brenner, F. Fazi, R. Villa, A. Gutierrez, M. Buschbeck, C. Nervi, S. Minucci, F. Fuks, and L. Di Croce (2008)
Mol. Cell. Biol.
28, 5912-5923
|Abstract »|Full Text »|PDF »
Expanding the Use of Retinoids in Acute Myeloid Leukemia: Spotlight on Bexarotene.
S. McNamara and W. H. Miller Jr. (2008)
Clin. Cancer Res.
14, 5311-5313
|Full Text »|PDF »
Signaling silence--breaking ground and spreading out.
Epigenetic Modification of CCAAT/Enhancer Binding Protein {alpha} Expression in Acute Myeloid Leukemia.
B. Hackanson, K. L. Bennett, R. M. Brena, J. Jiang, R. Claus, S.-S. Chen, N. Blagitko-Dorfs, K. Maharry, S. P. Whitman, T. D. Schmittgen, et al. (2008)
Cancer Res.
68, 3142-3151
|Abstract »|Full Text »|PDF »
Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation.
F. Pettersson and W. H. Miller Jr (2008)
Blood
111, 2498
|Full Text »|PDF »
Chromatin modifications induced by PML-RAR{alpha} repress critical targets in leukemogenesis as analyzed by ChIP-Chip.
C. Hoemme, A. Peerzada, G. Behre, Y. Wang, M. McClelland, K. Nieselt, M. Zschunke, C. Disselhoff, S. Agrawal, F. Isken, et al. (2008)
Blood
111, 2887-2895
|Abstract »|Full Text »|PDF »
DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia.
A. Glasow, A. Barrett, K. Petrie, R. Gupta, M. Boix-Chornet, D.-C. Zhou, D. Grimwade, R. Gallagher, M. von Lindern, S. Waxman, et al. (2008)
Blood
111, 2374-2377
|Abstract »|Full Text »|PDF »
The Dynamic Epigenome and its Implications in Toxicology.
Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome.
A. O. Soriano, H. Yang, S. Faderl, Z. Estrov, F. Giles, F. Ravandi, J. Cortes, W. G. Wierda, S. Ouzounian, A. Quezada, et al. (2007)
Blood
110, 2302-2308
|Abstract »|Full Text »|PDF »
Deoxyribonucleic Acid Methyl Transferases 3a and 3b Associate with the Nuclear Orphan Receptor COUP-TFI during Gene Activation.
R. Gallais, F. Demay, P. Barath, L. Finot, R. Jurkowska, R. Le Guevel, F. Gay, A. Jeltsch, R. Metivier, and G. Salbert (2007)
Mol. Endocrinol.
21, 2085-2098
|Abstract »|Full Text »|PDF »
Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia.
F. Fazi, G. Zardo, V. Gelmetti, L. Travaglini, A. Ciolfi, L. Di Croce, A. Rosa, I. Bozzoni, F. Grignani, F. Lo-Coco, et al. (2007)
Blood
109, 4432-4440
|Abstract »|Full Text »|PDF »
Epigenetic gene silencing in cancer: the DNA hypermethylome.
Molecular Mechanisms of Transactivation and Doxorubicin-mediated Repression of survivin Gene in Cancer Cells.
P.-O. Esteve, H. G. Chin, and S. Pradhan (2007)
J. Biol. Chem.
282, 2615-2625
|Abstract »|Full Text »|PDF »
Differential Recruitment of Methylated CpG Binding Domains by the Orphan Receptor GCNF Initiates the Repression and Silencing of Oct4 Expression.
P. Gu, D. Le Menuet, A. C.-K. Chung, and A. J. Cooney (2006)
Mol. Cell. Biol.
26, 9471-9483
|Abstract »|Full Text »|PDF »
Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repression.
R. Claus, M. Fliegauf, M. Stock, J. A. Duque, M. Kolanczyk, and M. Lubbert (2006)
J. Leukoc. Biol.
80, 1462-1472
|Abstract »|Full Text »|PDF »
The cancer epigenome--components and functional correlates.
A. H. Ting, K. M. McGarvey, and S. B. Baylin (2006)
Genes & Dev.
20, 3215-3231
|Abstract »|Full Text »|PDF »
Identifying gene regulatory elements by genomic microarray mapping of DNaseI hypersensitive sites.
G. A. Follows, P. Dhami, B. Gottgens, A. W. Bruce, P. J. Campbell, S. C. Dillon, A. M. Smith, C. Koch, I. J. Donaldson, M. A. Scott, et al. (2006)
Genome Res.
16, 1310-1319
|Abstract »|Full Text »|PDF »
Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA.
M. Shamay, A. Krithivas, J. Zhang, and S. D. Hayward (2006)
PNAS
103, 14554-14559
|Abstract »|Full Text »|PDF »
Sequential Valproic Acid/All-trans Retinoic Acid Treatment Reprograms Differentiation in Refractory and High-Risk Acute Myeloid Leukemia..
G. Cimino, F. Lo-Coco, S. Fenu, L. Travaglini, E. Finolezzi, M. Mancini, M. Nanni, A. Careddu, F. Fazi, F. Padula, et al. (2006)
Cancer Res.
66, 8903-8911
|Abstract »|Full Text »|PDF »
DNA Damage-induced Down-regulation of Human Cdc25C and Cdc2 Is Mediated by Cooperation between p53 and Maintenance DNA (Cytosine-5) Methyltransferase 1.
G. L. Gac, P.-O. Esteve, C. Ferec, and S. Pradhan (2006)
J. Biol. Chem.
281, 24161-24170
|Abstract »|Full Text »|PDF »
Cytoplasmic Function of Mutant Promyelocytic Leukemia (PML) and PML-Retinoic Acid Receptor-{alpha}.
C. Bellodi, K. Kindle, F. Bernassola, D. Dinsdale, A. Cossarizza, G. Melino, D. Heery, and P. Salomoni (2006)
J. Biol. Chem.
281, 14465-14473
|Abstract »|Full Text »|PDF »
In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR{alpha} blockade in the pathogenesis of acute promyelocytic leukemia.
H. Matsushita, P. P. Scaglioni, M. Bhaumik, E. M. Rego, L. F. Cai, S. M. Majid, H. Miyachi, A. Kakizuka, W. H. Miller Jr., and P. P. Pandolfi (2006)
J. Exp. Med.
203, 821-828
|Abstract »|Full Text »|PDF »
CpG Sites Preferentially Methylated by Dnmt3a in Vivo.
M. Oka, N. Rodic, J. Graddy, L.-J. Chang, and N. Terada (2006)
J. Biol. Chem.
281, 9901-9908
|Abstract »|Full Text »|PDF »
Recruitment of the Histone Methyltransferase SUV39H1 and Its Role in the Oncogenic Properties of the Leukemia-Associated PML-Retinoic Acid Receptor Fusion Protein.
R. Carbone, O. A. Botrugno, S. Ronzoni, A. Insinga, L. Di Croce, P. G. Pelicci, and S. Minucci (2006)
Mol. Cell. Biol.
26, 1288-1296
|Abstract »|Full Text »|PDF »
The methyl-CpG binding protein MBD1 is required for PML-RAR{alpha} function.
R. Villa, L. Morey, V. A. Raker, M. Buschbeck, A. Gutierrez, F. De Santis, M. Corsaro, F. Varas, D. Bossi, S. Minucci, et al. (2006)
PNAS
103, 1400-1405
|Abstract »|Full Text »|PDF »
De novo CpG Island Methylation in Human Cancer Cells.
K.-W. Jair, K. E. Bachman, H. Suzuki, A. H. Ting, I. Rhee, R.-W. C. Yen, S. B. Baylin, and K. E. Schuebel (2006)
Cancer Res.
66, 682-692
|Abstract »|Full Text »|PDF »
The Biology of Acute Promyelocytic Leukemia and Its Impact on Diagnosis and Treatment.
Methylation of estrogen receptor {beta} promoter correlates with loss of ER-{beta} expression in mammary carcinoma and is an early indication marker in premalignant lesions.
A Rody, U Holtrich, C Solbach, K Kourtis, G von Minckwitz, K Engels, S Kissler, R Gatje, T Karn, and M Kaufmann (2005)
Endocr. Relat. Cancer
12, 903-916
|Abstract »|Full Text »|PDF »
Impaired Retinoic Acid (RA) Signal Leads to RAR{beta}2 Epigenetic Silencing and RA Resistance.
M. Ren, S. Pozzi, G. Bistulfi, G. Somenzi, S. Rossetti, and N. Sacchi (2005)
Mol. Cell. Biol.
25, 10591-10603
|Abstract »|Full Text »|PDF »
DNA Methyltransferase Inhibitors and the Development of Epigenetic Cancer Therapies.
Platelet-Derived Growth Factor-AA Is an Essential and Autocrine Regulator of Vascular Endothelial Growth Factor Expression in Non-Small Cell Lung Carcinomas.
Y. Shikada, Y. Yonemitsu, T. Koga, M. Onimaru, T. Nakano, S. Okano, S. Sata, K. Nakagawa, I. Yoshino, Y. Maehara, et al. (2005)
Cancer Res.
65, 7241-7248
|Abstract »|Full Text »|PDF »
The Theoretical Basis of Transcriptional Therapy of Cancer: Can It Be Put Into Practice?.
A. M. Melnick, K. Adelson, and J. D. Licht (2005)
J. Clin. Oncol.
23, 3957-3970
|Abstract »|Full Text »|PDF »
Epigenetic and Chromatin Modifiers As Targeted Therapy of Hematologic Malignancies.
Methylation Silencing of the Apaf-1 Gene in Acute Leukemia.
Y. Furukawa, K. Sutheesophon, T. Wada, M. Nishimura, Y. Saito, H. Ishii, and Y. Furukawa (2005)
Mol. Cancer Res.
3, 325-334
|Abstract »|Full Text »|PDF »
STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes.
Q. Zhang, H. Y. Wang, M. Marzec, P. N. Raghunath, T. Nagasawa, and M. A. Wasik (2005)
PNAS
102, 6948-6953
|Abstract »|Full Text »|PDF »
Chromatin modifying activity of leukaemia associated fusion proteins.
Valproic acid, in combination with all-trans retinoic acid and 5-aza-2'-deoxycytidine, restores expression of silenced RAR{beta}2 in breast cancer cells.
FLT3/ITD Mutation Signaling Includes Suppression of SHP-1.
P. Chen, M. Levis, P. Brown, K.-T. Kim, J. Allebach, and D. Small (2005)
J. Biol. Chem.
280, 5361-5369
|Abstract »|Full Text »|PDF »
Interplay of RUNX1/MTG8 and DNA Methyltransferase 1 in Acute Myeloid Leukemia.
S. Liu, T. Shen, L. Huynh, M. I. Klisovic, L. J. Rush, J. L. Ford, J. Yu, B. Becknell, Y. Li, C. Liu, et al. (2005)
Cancer Res.
65, 1277-1284
|Abstract »|Full Text »|PDF »
The Molecular Pathology of Acute Myeloid Leukemia.
Epigenomic Changes during Leukemia Cell Differentiation: Analysis of Histone Acetylation and Cytosine Methylation Using CpG Island Microarrays.
M. Nouzova, N. Holtan, M. M. Oshiro, R. B. Isett, J. L. Munoz-Rodriguez, A. F. List, M. L. Narro, S. J. Miller, N. C. Merchant, and B. W. Futscher (2004)
J. Pharmacol. Exp. Ther.
311, 968-981
|Abstract »|Full Text »|PDF »
Promoter Hypermethylation and Quantitative mRNA Expression of the Retinoic Acid Receptor {beta}2 Gene in Patients with Acute Myeloid Leukemia..
A. Rethmeier, P. Hokland, and A. Aggerholm (2004)
Blood (ASH Annual Meeting Abstracts)
104, 1065
|Abstract »
Relapse of Acute Promyelocytic Leukemia (APL) Is Associated with Increased Methylation of the Retinoic Acid Receptor-Beta2 (RAR{beta}2) Gene Promoter..
D.-C. Zhou, H. Kim, M. S. Tallman4, and R. E. Gallagher (2004)
Blood (ASH Annual Meeting Abstracts)
104, 1124
|Abstract »
Reprogramming of a melanoma genome by nuclear transplantation.
K. Hochedlinger, R. Blelloch, C. Brennan, Y. Yamada, M. Kim, L. Chin, and R. Jaenisch (2004)
Genes & Dev.
18, 1875-1885
|Abstract »|Full Text »|PDF »
Parent-of-Origin-Specific Binding of Nuclear Hormone Receptor Complexes in the H19-Igf2 Imprinting Control Region.
P. E. Szabo, G. P. Pfeifer, and J. R. Mann (2004)
Mol. Cell. Biol.
24, 4858-4868
|Abstract »|Full Text »|PDF »
The Fusion Oncoprotein PML-RAR{alpha} Induces Endoplasmic Reticulum (ER)-associated Degradation of N-CoR and ER Stress.
M. M. Khan, T. Nomura, T. Chiba, K. Tanaka, H. Yoshida, K. Mori, and S. Ishii (2004)
J. Biol. Chem.
279, 11814-11824
|Abstract »|Full Text »|PDF »
The Present State of Antineoplaston Research (1).
S. R. Burzynski (2004)
Integr Cancer Ther
3, 47-58
|Abstract »|PDF »
The Coiled-coil Domain Is the Structural Determinant for Mammalian Homologues of Drosophila Sina-mediated Degradation of Promyelocytic Leukemia Protein and Other Tripartite Motif Proteins by the Proteasome.
M. Fanelli, A. Fantozzi, P. De Luca, S. Caprodossi, S.-i. Matsuzawa, M. A. Lazar, P. G. Pelicci, and S. Minucci (2004)
J. Biol. Chem.
279, 5374-5379
|Abstract »|Full Text »|PDF »
Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromes.
M. T. Voso, A. Scardocci, F. Guidi, G. Zini, A. Di Mario, L. Pagano, S. Hohaus, and G. Leone (2004)
Blood
103, 698-700
|Abstract »|Full Text »|PDF »
Growth Suppression by Acute Promyelocytic Leukemia-Associated Protein PLZF Is Mediated by Repression of c-myc Expression.
M. J. McConnell, N. Chevallier, W. Berkofsky-Fessler, J. M. Giltnane, R. B. Malani, L. M. Staudt, and J. D. Licht (2003)
Mol. Cell. Biol.
23, 9375-9388
|Abstract »|Full Text »|PDF »
Retinoic Acid Receptor {alpha} Fusion to PML Affects Its Transcriptional and Chromatin-Remodeling Properties.
S. Segalla, L. Rinaldi, C. Kilstrup-Nielsen, G. Badaracco, S. Minucci, P. G. Pelicci, and N. Landsberger (2003)
Mol. Cell. Biol.
23, 8795-8808
|Abstract »|Full Text »|PDF »
Gene Silencing in Cancer in Association with Promoter Hypermethylation.
J. G. Herman and S. B. Baylin (2003)
N. Engl. J. Med.
349, 2042-2054
|Full Text »|PDF »
Functional Characterization of a Testis-Specific DNA Binding Activity at the H19/Igf2 Imprinting Control Region.
A. B. Bowman, J. M. Levorse, R. S. Ingram, and S. M. Tilghman (2003)
Mol. Cell. Biol.
23, 8345-8351
|Abstract »|Full Text »|PDF »
Hypermethylation-Associated Inactivation of Retinoic Acid Receptor {beta} in Human Esophageal Squamous Cell Carcinoma.
Y. Wang, M. Z. Fang, J. Liao, G.-Y. Yang, Y. Nie, Y. Song, C. So, X. Xu, L.-D. Wang, and C. S. Yang (2003)
Clin. Cancer Res.
9, 5257-5263
|Abstract »|Full Text »|PDF »
Predicting aberrant CpG island methylation.
F. A. Feltus, E. K. Lee, J. F. Costello, C. Plass, and P. M. Vertino (2003)
PNAS
100, 12253-12258
|Abstract »|Full Text »|PDF »
Progressive Alterations in Global and GC-Rich DNA Methylation during Tumorigenesis.
R. E. Watson, G. M. Curtin, D. J. Doolittle, and J. I. Goodman (2003)
Toxicol. Sci.
75, 289-299
|Abstract »|Full Text »|PDF »
Establishment and Maintenance of Genomic Methylation Patterns in Mouse Embryonic Stem Cells by Dnmt3a and Dnmt3b.
T. Chen, Y. Ueda, J. E. Dodge, Z. Wang, and E. Li (2003)
Mol. Cell. Biol.
23, 5594-5605
|Abstract »|Full Text »|PDF »
An activated receptor tyrosine kinase, TEL/PDGF{beta}R, cooperates with AML1/ETO to induce acute myeloid leukemia in mice.
J. L. Grisolano, J. O'Neal, J. Cain, and M. H. Tomasson (2003)
PNAS
100, 9506-9511
|Abstract »|Full Text »|PDF »
Frequent Hypomethylation of Multiple Genes Overexpressed in Pancreatic Ductal Adenocarcinoma.
N. Sato, A. Maitra, N. Fukushima, N. T. van Heek, H. Matsubayashi, C. A. Iacobuzio-Donahue, C. Rosty, and M. Goggins (2003)
Cancer Res.
63, 4158-4166
|Abstract »|Full Text »|PDF »
Cooperation of Cytokine Signaling with Chimeric Transcription Factors in Leukemogenesis: PML-Retinoic Acid Receptor Alpha Blocks Growth Factor-Mediated Differentiation.
V. T. Phan, D. B. Shultz, B.-T. H. Truong, T. J. Blake, A. L. Brown, T. J. Gonda, M. M. Le Beau, and S. C. Kogan (2003)
Mol. Cell. Biol.
23, 4573-4585
|Abstract »|Full Text »|PDF »
Genomic targets of the human c-Myc protein.
P. C. Fernandez, S. R. Frank, L. Wang, M. Schroeder, S. Liu, J. Greene, A. Cocito, and B. Amati (2003)
Genes & Dev.
17, 1115-1129
|Abstract »|Full Text »|PDF »
Cadherin-13, a Mediator of Calcium-Dependent Cell-Cell Adhesion, Is Silenced by Methylation in Chronic Myeloid Leukemia and Correlates With Pretreatment Risk Profile and Cytogenetic Response to Interferon Alfa.
J. Roman-Gomez, J. A. Castillejo, A. Jimenez, F. Cervantes, C. Boque, L. Hermosin, A. Leon, A. Granena, D. Colomer, A. Heiniger, et al. (2003)
J. Clin. Oncol.
21, 1472-1479
|Abstract »|Full Text »|PDF »
A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657.
J. Sohal, V. T. Phan, P. V. Chan, E. M. Davis, B. Patel, L. M. Kelly, T. J. Abrams, A. M. O'Farrell, D. G. Gilliland, M. M. Le Beau, et al. (2003)
Blood
101, 3188-3197
|Abstract »|Full Text »|PDF »
Global down-regulation of HOX gene expression in PML-RARalpha + acute promyelocytic leukemia identified by small-array real-time PCR.
A. Thompson, M. F. Quinn, D. Grimwade, C. M. O'Neill, M. R. Ahmed, S. Grimes, M. F. McMullin, F. Cotter, and T. R. J. Lappin (2003)
Blood
101, 1558-1565
|Abstract »|Full Text »|PDF »
CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia.
B.-T. H. Truong, Y.-J. Lee, T. A. Lodie, D. J. Park, D. Perrotti, N. Watanabe, H. P. Koeffler, H. Nakajima, D. G. Tenen, and S. C. Kogan (2003)
Blood
101, 1141-1148
|Abstract »|Full Text »|PDF »
Epigenetic Regulation of a Novel Tumor Suppressor Gene (hDAB2IP) in Prostate Cancer Cell Lines.
H. Chen, S. Toyooka, A. F. Gazdar, and J.-T. Hsieh (2003)
J. Biol. Chem.
278, 3121-3130
|Abstract »|Full Text »|PDF »
Methyl-CpG-binding Domain Protein-2 Mediates Transcriptional Repression Associated with Hypermethylated GSTP1 CpG Islands in MCF-7 Breast Cancer Cells.
Inhibitors of Histone Deacetylase and DNA Methyltransferase Synergistically Activate the Methylated Metallothionein I Promoter by Activating the Transcription Factor MTF-1 and Forming an Open Chromatin Structure.
K. Ghoshal, J. Datta, S. Majumder, S. Bai, X. Dong, M. Parthun, and S. T. Jacob (2002)
Mol. Cell. Biol.
22, 8302-8319
|Abstract »|Full Text »|PDF »
A Novel Dnmt3a Isoform Produced from an Alternative Promoter Localizes to Euchromatin and Its Expression Correlates with Active de Novo Methylation.
T. Chen, Y. Ueda, S. Xie, and E. Li (2002)
J. Biol. Chem.
277, 38746-38754
|Abstract »|Full Text »|PDF »
Alternative Promoter Identified between a Hypermethylated Upstream Region of Repetitive Elements and a CpG Island in Human ABO Histo-blood Group Genes.
Y. Kominato, Y. Hata, H. Takizawa, K. Matsumoto, K. Yasui, J.-i. Tsukada, and F.-i. Yamamoto (2002)
J. Biol. Chem.
277, 37936-37948
|Abstract »|Full Text »|PDF »
Dnmt3L is a transcriptional repressor that recruits histone deacetylase.
R. Deplus, C. Brenner, W. A. Burgers, P. Putmans, T. Kouzarides, Y. d. Launoit, and F. Fuks (2002)
Nucleic Acids Res.
30, 3831-3838
|Abstract »|Full Text »|PDF »
Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation.
Q N Vo, J Geradts, M L Gulley, D A Boudreau, J C Bravo, and B G Schneider (2002)
J. Clin. Pathol.
55, 669-675
|Abstract »|Full Text »|PDF »
Methylation and the Genome: the Power of a Small Amendment.
Loss of Retinoic Acid Receptor {beta} Gene Expression Is Linked to Aberrant Histone H3 Acetylation in Lung Cancer Cell Lines.
Y.-A. Suh, H.-Y. Lee, A. Virmani, J. Wong, K. K. Mann, W. H. Miller Jr., A. Gazdar, and J. M. Kurie (2002)
Cancer Res.
62, 3945-3949
|Abstract »|Full Text »|PDF »
The Oncoprotein Set/TAF-1beta , an Inhibitor of Histone Acetyltransferase, Inhibits Active Demethylation of DNA, Integrating DNA Methylation and Transcriptional Silencing.
N. Cervoni, N. Detich, S.-b. Seo, D. Chakravarti, and M. Szyf (2002)
J. Biol. Chem.
277, 25026-25031
|Abstract »|Full Text »|PDF »
Methylation Matters: Modeling a Manageable Genome.
J. M. Ordway and T. Curran (2002)
Cell Growth Differ.
13, 149-162
|Full Text »|PDF »
